IBTimes Logo

GlaxoSmithKline in talks to buy Stiefel

British-based pharmaceuticals firm GlaxoSmithKline PLC is in talks to buy privately-owned U.S. skincare specialist Stiefel Laboratories, a source familiar with the situation said on Sunday.
More news
IBTimes Logo

Sirtris Pharmaceuticals Shares rose 80% after Glaxo offers $720 Million

Shares of Sirtris Pharmaceuticals rose as much as 80.46 percent to $22.07 in after trading hours on Tuesday in the New York Stock Exchange as healthcare group GlaxoSmithKline Plc. entered into a definitive agreement to acquire Sirtris for $720 million in a cash tender offer of $22.50 per share.
IBTimes Logo

FTSE steady on Monday

The FTSE 100 share index was almost unchanged as Monday came to an end, with the index going down only 3.5 points to 6,053.0 (down 0.06 per cent).
IBTimes Logo

China tries charm to convince world its goods safe

China went on a charm offensive on Wednesday to convince a skeptical world its products are safe, as a new poll in the United States found 78 percent of Americans were worried about the safety of Chinese goods.
IBTimes Logo

Glaxo diabetes drug should stay on market: U.S. panel

GlaxoSmithKline Plc's diabetes drug Avandia should stay on the U.S. market, even though data suggest it may increase the risk of a heart attack for some patients, an advisory panel said on Monday in a 22-1 vote.
IBTimes Logo

FDA scientist says pull Avandia

GlaxoSmithKline Plc's widely used diabetes drug Avandia should be pulled off the market, U.S. Food and Drug Administration scientist David Graham said in a presentation prepared for delivery on Monday.
IBTimes Logo

FDA to ask if Avandia should stay on market

The U.S. Food and Drug Administration will ask outside advisers if GlaxoSmithKline Plc's diabetes drug Avandia should be taken off the market or remain on sale with new warnings or limits, a summary released on Thursday said.
IBTimes Logo

GSK Submits Tykerb for Market Approval

GlaxoSmithKine plc has announced today the submission of a New Drug Application to the United States Food and Drug Administration (FDA), for approval to market.
IBTimes Logo

US Approves Merck's Cervical Cancer Vaccine

The first vaccine to prevent cervical cancer won U.S. approval on Thursday when health officials cleared a Merck & Co. Inc. shot to block a sexually transmitted infection that causes the deadly disease.
IBTimes Logo

Bayer Not Seeking Pfizer Consumer Health Unit

German drugs and chemicals group Bayer is not currently considering a bid for Pfizer's consumer healthcare business, an industry source familiar with the matter told Reuters on Saturday.


IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.